4//SEC Filing
Havey Adam 4
Accession 0001367644-22-000016
CIK 0001367644other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 6:49 PM ET
Size
6.7 KB
Accession
0001367644-22-000016
Insider Transaction Report
Form 4
Havey Adam
EVP, BioDefense Division
Transactions
- Award
Common Stock
2022-02-22+1,836→ 40,026 total - Tax Payment
Common Stock
2022-02-22$42.23/sh−1,980$83,615→ 38,046 total
Footnotes (2)
- [F1]Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 6,917 shares of common stock, which is in excess of the 5,081 shares previously reported on February 28, 2019.
- [F2]Represents shares of common stock withheld to pay taxes.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeother
Related Parties
1- filerCIK 0001514588
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 6:49 PM ET
- Size
- 6.7 KB